The Quadra Assura MP™ CRT-D brings MultiPoint™ Pacing, an exclusive Abbott technology, to cardiac resynchronization therapy defibrillators (CRT-Ds).
MultiPoint Pacing technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to provide you with CRT options to change:
The Quadra Assura MP CRT-D with Quartet™ quadripolar LV pacing lead, with its four pacing electrodes and 10 pacing vectors, provides more options and greater control in CRT response.
The recent IDE study1 post-hoc subanalysis (n = 199) showed that wider cathode spacing and near-simultaneous intraventricular timing delays provide best MultiPoint Pacing technology response at 87 percent and “super-response” at 54 percent (52 patients).1
This evidence builds on our quadripolar standard of care, which has offered you more options to pace at the preferred LV site, resulting in:
The Quadra Assura MP CRT-D is MR conditional when used with specific leads and lead lengths, and allows full-body, 1.5T MRI scans that meet certain scan conditions.*
The Quadra Assura MP CRT-D offers Auto VectSelect Quartet™ Test that:
Pacing at the tissue site of latest activation improves:
The Quadra Assura MP™ CRT-D is one of our heart failure management therapies. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about our approach to heart failure management.
*See MRI Ready Systems Manual for device and lead combinations and associated MRI scan parameters.